stock · yahoo

Terumo Corporation

4543.T

$14.81
0.03 (0.18%)
polled · warming up

Aşağıda Terumo Corporation (4543.T) için canlı hisse fiyatı, 1 yıllık grafik, 8 indikatör (RSI, MACD, Bollinger, MA, EMA, Stochastic, ATR, Hacim) ve karşılaştırma modu var. Portföyüne ekleyebilir, izleme listene yıldız atabilir veya fiyat alarmı kurabilirsin.

Day
+0.18%
+4.00
Week
-5.04%
-121.00
Month
+14.63%
+291.00
Year
-12.24%
-318.00
Prev close
$14.78
Volume
$9.49K
Market cap
$21.84B
Currency
USD (native JPY)

Financials

52w high
¥2,818
52w low
¥1,900
52w change
-12.28%
Day high
¥2,322
Day low
¥2,271.5
P/E (TTM)
24.73
Forward P/E
22.39
PEG
2.18
Price / Book
2.12
Beta (5Y)
0.18
Enterprise value
3.5T
EV / Revenue
3.1
EV / EBITDA
12.3
EPS (TTM)
¥92.18
Forward EPS
¥101.83
Dividend yield
1.58%
Dividend rate
¥36
Payout ratio
32.57%
Revenue (TTM)
1.13T
EBITDA
285.04B
Free cash flow
64.11B
Total cash
280.49B
Total debt
428.02B
Debt / Equity
27.01
Current ratio
1.59
Quick ratio
0.92
Profit margin
12.01%
Gross margin
52.74%
Return on assets
5.73%
Return on equity
9.21%
Shares outstanding
1.48B
Float
1.45B
Sector: HealthcareIndustry: Medical Instruments & SuppliesHQ: Japanwww.terumo.com

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through four segments: Cardiac and Vascular Company, Medical Care Solutions Company, Blood and Cell Technologies Company, and Terumo Organ Technologies. The Cardiac and Vascular Company segment offers angiographic guidewires, angiographic catheters, introducer sheaths, vascular closure devices, PTCA balloon catheters, coronary stents, self-expanding peripheral stents, intravascular ultrasound systems, imaging catheters, and others; coils, stents, and intrasaccular devices for treating cerebral aneurysm; embolization systems, aspiration catheters, and clot retrievers for treating ischemic stroke and others; oxygenators, cardio-pulmonary bypass systems, and others; and artificial vascular stent grafts, and others. The Medical Care Solutions Company segment provides syringes, infusion pumps, syringe pumps, infusion lines, I.V. solutions, peritoneal dialysis fluids, pain management adhesion barriers, and others; blood glucose monitoring systems, disposable needles for pen-injector, insulin patch pumps, blood pressure monitors, digital thermometers, and others; and contract manufacturing of prefilled syringes, devices to pharmaceutical companies for use in drug kits, such as prefillable syringes, needles for pharmaceutical packaging business, and others. The Blood and Cell Technologies Company segment offers blood bags, component collection systems, automated blood processing systems, pathogen reduction systems, centrifugal apheresis systems, cell expansion systems, and others. The Terumo Organ Technologies segment provides organ preservation devices. The company was formerly known as Sekisen Ken-onki Corporation and changed its name to Terumo Corporation in October 1974. Terumo Corporation was incorporated in 1921 and is headquartered in Shibuya, Japan.

Analyst & Risk

Consensus
Buy
Mean rating1.57 / 5
Analysts13
Next earnings2026-08-06
Strong buy 2Buy 9Hold 3
Analyst price target
¥2,962.31
Mean target · 13 analysts
+29.9%
upside
Low ¥2,100Now ¥2,280High ¥3,700
Beta (vs S&P 500)
0.18
very stable
52-week change
-12.28%
Debt / Equity
27.01
very high leverage
Current ratio
1.59
Quick ratio
0.92
ROE
9.21%
ROA
5.73%
PEG ratio
2.18
richly valued
EV / Revenue
3.1
EV / EBITDA
12.3
Revenue growth
13.80%
Earnings growth
43.60%
EBITDA
285.04B
Free cash flow
64.11B
Total cash
280.49B
Total debt
428.02B
Insider holdings
2.56%
Institutional
65.15%

Canlı tartışma

Giriş to join the discussion.

  • Henüz yorum yok. İlk siz olun.